FHA
ITCI
First Horizon Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-148
| Closed | -$19.5K | – | 2553 |
|
|
2025
Q1 | $19.5K | Sell |
148
-174
| -54% | -$23K | ﹤0.01% | 1339 |
|
|
2024
Q4 | $26.9K | Buy |
322
+51
| +19% | +$4.26K | ﹤0.01% | 1219 |
|
|
2024
Q3 | $19.8K | Hold |
271
| – | – | ﹤0.01% | 1358 |
|
|
2024
Q2 | $18.6K | Buy |
271
+87
| +47% | +$5.96K | ﹤0.01% | 1304 |
|
|
2024
Q1 | $12.7K | Hold |
184
| – | – | ﹤0.01% | 1502 |
|
|
2023
Q4 | $13.2K | Hold |
184
| – | – | ﹤0.01% | 1491 |
|
|
2023
Q3 | $9.58K | Hold |
184
| – | – | ﹤0.01% | 1529 |
|
|
2023
Q2 | $11.7K | Hold |
184
| – | – | ﹤0.01% | 1482 |
|
|
2023
Q1 | $9.96K | Hold |
184
| – | – | ﹤0.01% | 1562 |
|
|
2022
Q4 | $9.74K | Hold |
184
| – | – | ﹤0.01% | 1575 |
|
|
2022
Q3 | $8K | Sell |
184
-56
| -23% | -$2.44K | ﹤0.01% | 1623 |
|
|
2022
Q2 | $13K | Buy |
+240
| New | +$13K | ﹤0.01% | 1489 |
|
|
2022
Q1 | – | Sell |
-161
| Closed | -$7K | – | 2362 |
|
|
2021
Q4 | $7K | Buy |
+161
| New | +$7K | ﹤0.01% | 1671 |
|